CARPS: Cardiovascular, Allergy, and Respiratory Disease Summit

2017 CARPS includes 28 lectures:

  1. Course Overview (9:34)
  2. Dyslipidemia: Assessment and Treatment of Cardiovascular Risk: Applying 2016 ACC Recommendations (52:10)
  3. Your Patient has ACS/AMI: Now What? (50:11)
  4. Q&A Panel Session (11:22)
  5. Enteroendocrine System and Cardio-Pulmonary Health (49:11)
  6. Atrial Fibrillation: Choosing Anticoagulation Based on Patient Needs (49:40)
  7. Women and Heart Disease: Symptom Recognition & Moving to Care (47:37)
  8. Q&A Panel Session (11:34)
  9. Heart Failure Practical Approaches (50:30)
  10. Hypertension: How Low to Go When Treating Older Adults (54:08)
  11. Asthma: Comparison of the NHLBI and GINA Guidelines (54:19)
  12. Q&A Panel Session (20:24)
  13. Diabetes Interactive Cases (50:31)
  14. HTN in CKD: How Should I Be Treating It? (54:27)
  15. Cardiology Cases: How Not to Lose Your License (36:15)
  16. Q&A Panel Session (20:49)
  17. COPD: Updated 2017 GOLD Guidelines (39:41)
  18. Differentiate Acute Bronchitis and Community Acquired Pneumonia (This session not eligible for CE/CME credit) (40:50)
  19. Allergic Rhinitis Diagnosis and Treatment (55:38)
  20. Q&A Panel Session (15:18)
  21. Update on Sinusitis & Otitis (This session not eligible for CE/CME credit) (47:09)
  22. Q&A Panel Session (6:04)
  23. Severe and Difficult to Treat Asthma: What to Do When Asthma is Out of Control (41:58)
  24. Smoking Cessation (50:46)
  25. Q&A Panel Session (11:58)
  26. Anaphylaxis Controversy and Consensus (54:04)
  27. Evaluation of the Patient with a Chronic Cough (43:12)
  28. Q&A Panel Session (13:54)

Meet Our Expert Faculty

Our Energetic and Knowledgeable NP and PA Faculty Will Provide You with State-of-the-Art Updates in Cardiovascular, Allergy and Respiratory Care.

CME Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Global Academy for Medical Education, Inc. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity for 17.0 contact hour(s) is provided by the Postgraduate Institute for Medicine. Designated for 6.5 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Nursing Continuing Education
This educational activity for 17.0 contact hours is provided by Postgraduate Institute for Medicine.

Physician Credit Designation
The University of Cincinnati designates this Live Activity for a maximum of 17.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants Credit Designation
The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME.

Credit Availability
This activity has a start date of 10/1/17 and an end date 9/30/19.

Target Audience

The Cardiovascular, Allergy and Respiratory Summit (CARPS) self-study program is intended for primary care NPs, PAs, and Registered Nurses as well as other health care clinicians interested in diagnosing and treating prevalent conditions such as cardiovascular, allergy and respiratory disease.

Learning Objectives

Upon completion of the Cardiovascular, Allergy and Respiratory Summit (CARPS) self-study program, participants will be able to:

  • Analyze disease patterns and apply pattern recognition to the clinical evaluation and differential diagnoses in patients with respiratory disease, allergy and cardiovascular disease (CVD).
  • Integrate into daily practice evidence-based recommendations for the clinical management of respiratory disease, allergy and CVD, including aggressive treatment and treatment-to-target strategies.
  • Evaluate the safety and efficacy of the various classes of pharmaceutical and biologic agents in the treatment of chronic obstructive pulmonary disease (COPD), asthma, allergic rhinitis, atrial fibrillation, hypertension, hyperlipidemia, arrhythmia and congestive heart failure (CHD).
  • Discuss the currently available and emerging medications that target established and newly recognized pathways in the pathogenesis of respiratory disease, allergy and CVD.
  • Incorporate new therapies in appropriately selected patients.
  • Provide evidence-based patient education on treatment options, use of inhalers and breathing aids, and the role of home care.
  • Review routine practice protocols for use of the most appropriate outcomes measures.
  • Formulate evidence-based lifestyle management plans incorporating updated recommendations for patients with respiratory disease, allergy and CVD.
  • Develop individualized strategies for respiratory, allergy and cardiovascular therapy.
  • Recognize the need for referral to a pulmonologist, allergist or cardiologist and understand the role of appropriate handoff, documentation and communication in the referral process.